Yaokang Biology announced that shareholder Qingdao Guoyao reduced its holdings of the company's shares by 888,190 shares through block trading, accounting for 0.22% of the total share capital of the company. Before this equity change, Qingdao Guoyao held 21,388,190 shares of the company, accounting for 5.22% of the total share capital. After this equity change, Qingdao Guoyao held 20,500,000 shares of the company, accounting for 5.00% of the total share capital. This equity change is the implementation of the previously disclosed shareholding reduction plan as a shareholder holding more than 5% but not the largest shareholder.
药康生物：持股5%以上股东青岛国药持股比例降至5%以下
Yao Kang Biology: Shareholders holding more than 5% of the shares, Qingdao National Pharmaceutical's shareholding ratio has decreased to less than 5%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated